PVLA – palvella therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Palvella's Phase III Success And Fast Track Status Test Current Valuation [Yahoo! Finance]
Palvella Therapeutics (PVLA) had its price target raised by Chardan Capital from $210.00 to $240.00. They now have a "buy" rating on the stock.
Palvella Therapeutics Inc (PVLA) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
Form 4 PALVELLA THERAPEUTICS, For: Apr 15 Filed by: Goin Kathleen
Form 4 PALVELLA THERAPEUTICS, For: Apr 13 Filed by: Doux John
Form 3 PALVELLA THERAPEUTICS, For: Apr 13 Filed by: Doux John
Form 144 PALVELLA THERAPEUTICS, Filed by: Goin Kathleen
Form 8-K PALVELLA THERAPEUTICS, For: Apr 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.